Autolus Therapeutics plc Quarterly Accounts Payable, Current in USD from Q3 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Autolus Therapeutics plc quarterly Accounts Payable, Current history and growth rate from Q3 2017 to Q4 2024.
  • Autolus Therapeutics plc Accounts Payable, Current for the quarter ending December 31, 2024 was $1.97M, a 1812% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.97M +$1.87M +1812% Dec 31, 2024 10-K 2025-03-20
Q3 2024 $1.42M +$757K +115% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.1M -$2.78M -71.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.4M +$1.05M +296% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 $103K -$428K -80.6% Dec 31, 2023 10-K 2025-03-20
Q3 2023 $661K +$327K +97.9% Sep 30, 2023 10-K 2024-03-21
Q2 2023 $3.88M +$3.72M +2294% Jun 30, 2023 10-K 2024-03-21
Q1 2023 $353K +$200K +131% Mar 31, 2023 10-K 2024-03-21
Q4 2022 $531K +$100K +23.2% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $334K Sep 30, 2022 10-K 2024-03-21
Q2 2022 $162K Jun 30, 2022 10-K 2024-03-21
Q1 2022 $153K -$2.11M -93.2% Mar 31, 2022 10-K 2024-03-21
Q4 2021 $431K -$1.83M -81% Dec 31, 2021 20-F 2023-03-07
Q1 2021 $2.26M +$1.2M +114% Mar 31, 2021 6-K 2021-05-06
Q4 2020 $2.26M +$1.19M +111% Dec 31, 2020 20-F 2022-03-10
Q3 2020 $2M -$736K -26.9% Sep 30, 2020 6-K 2020-11-05
Q2 2020 $626K -$2.52M -80.1% Jun 30, 2020 6-K 2020-08-06
Q1 2020 $1.06M Mar 31, 2020 6-K 2020-05-07
Q4 2019 $1.08M -$947K -46.8% Dec 31, 2019 20-F 2021-03-04
Q3 2019 $2.73M -$303K -9.98% Sep 30, 2019 6-K 2019-11-07
Q2 2019 $3.14M Jun 30, 2019 6-K 2019-08-08
Q4 2018 $2.02M Dec 31, 2018 20-F 2020-03-03
Q3 2018 $3.04M +$1.09M +56% Sep 30, 2018 20-F 2019-02-25
Q3 2017 $1.95M Sep 30, 2017 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.